Bakkus MH - Search Results

1

Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma.

Bakkus MH, Bouko Y, Samson D, Apperley JF, Thielemans K, Van Camp B, Benner A, Goldschmidt H, Moos M, Cremer FW. Bakkus MH, et al. Br J Haematol. 2004 Sep;126(5):665-74. doi: 10.1111/j.1365-2141.2004.05120.x. Br J Haematol. 2004. PMID: 15327517 Free article.

2

Persistence of residual tumour cells after cytokine-mediated ex vivo expansion of mobilized CD34+ blood cells in multiple myeloma.

Van Riet I, Juge-Morineau N, Schots R, De Waele M, De Greef C, Thielemans K, Van Camp B, Bakkus M. Van Riet I, et al. Br J Haematol. 1997 Feb;96(2):403-11. doi: 10.1046/j.1365-2141.1997.d01-2038.x. Br J Haematol. 1997. PMID: 9029033 Free article.

3

Use of quantitative ASO-PCR to predict relapse in multiple myeloma.

Cooke F, Bakkus M, Thielemans K, Pico JL, Apperley JF, Samson D. Cooke F, et al. Br J Haematol. 1999 Apr;105(1):317-9. Br J Haematol. 1999. PMID: 10366251 Free article. No abstract available.

4

Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell.

Bakkus MH, Van Riet I, Van Camp B, Thielemans K. Bakkus MH, et al. Br J Haematol. 1994 May;87(1):68-74. doi: 10.1111/j.1365-2141.1994.tb04872.x. Br J Haematol. 1994. PMID: 7947257

5

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.

Bourhis JH, Bouko Y, Koscielny S, Bakkus M, Greinix H, Derigs G, Salles G, Feremans W, Apperley J, Samson D, Björkstrand B, Niederwieser D, Gahrton G, Pico JL, Goldschmidt H; European Group for Blood and Marrow Transplantation. Bourhis JH, et al. Haematologica. 2007 Aug;92(8):1083-90. doi: 10.3324/haematol.10535. Epub 2007 Jul 20. Haematologica. 2007. PMID: 17640853 Free article. Clinical Trial.

6

Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) DNA sequences are absent in leukapheresis products and ex vivo expanded CD34+ cells from multiple myeloma patients.

De Greef C, Van De Voorde W, Bakkus M, Corthals J, Heirman C, Schots R, Lacor P, Van Camp B, Van Riet I. De Greef C, et al. Br J Haematol. 1999 Sep;106(4):1033-6. doi: 10.1046/j.1365-2141.1999.01628.x. Br J Haematol. 1999. PMID: 10520008 Free article.

7

Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation.

Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thielemans K. Bakkus MH, et al. Blood. 1992 Nov 1;80(9):2326-35. Blood. 1992. PMID: 1421403 Free article.

8

The clonogenic precursor cell in multiple myeloma.

Bakkus MH, Van Riet I, De Greef C, Van Camp B, Thielemans K. Bakkus MH, et al. Leuk Lymphoma. 1995 Jul;18(3-4):221-9. doi: 10.3109/10428199509059611. Leuk Lymphoma. 1995. PMID: 8535186 Review.

9

Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient.

Bakkus MH, Schots R, Gomez La Fuente PB, Van Riet I, Thielemans K, De Waele M, Van Camp B. Bakkus MH, et al. Eur J Haematol. 2000 Nov;65(5):348-55. doi: 10.1034/j.1600-0609.2000.065005348.x. Eur J Haematol. 2000. PMID: 11092467

10

Myeloma isotype-switch variants in the murine 5T myeloma model: evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour.

Bakkus MH, Asosingh K, Vanderkerken K, Thielemans K, Hagemeijer A, De Raeve H, Van Camp B. Bakkus MH, et al. Leukemia. 2001 Jul;15(7):1127-32. doi: 10.1038/sj.leu.2402164. Leukemia. 2001. PMID: 11455984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters